Pediatric brain tumors are characterized by frequent complications due to intractable epilepsy compared to adult brain tumors. However, the genetic cause of refractory epilepsy in pediatric brain tumors has not been elucidated yet, and it is difficult to treat patients because the tumors do not respond to existing antiepileptic drugs and debilitate children’s development.
A research team led by Professor Jeong Ho Lee of the Graduate School of Medical Science and Engineering has recently identified a neuronal BRAF somatic mutation that causes intrinsic epileptogenicity in pediatric brain tumors. Their research results were published online in Nature Medicine on September 17.
The research team studied patients’ tissue diagnosed with ganglioglioma (GG), one of the main causes of tumor-associated intractable epilepsy, and found that the BRAF V600E somatic mutation is involved in the development of neural stem cells by using deep DNA sequencing. This mutation was carried out in an animal model to reproduce the pathology of GG and to observe seizures to establish an animal model for the treatment of epileptic seizures caused by pediatric brain tumors.
Using immunohistochemical and transcriptome analysis, they realized that the BRAF V600E mutation that arose in early progenitor cells during embryonic brain formation led to the acquisition of intrinsic epileptogenic properties in neuronal lineage cells, whereas tumorigenic properties were attributed to a high proliferation of glial lineage cells exhibiting the mutation. Notably, researchers found that seizures in mice were significantly alleviated by intraventricular infusion of the BRAF V600E inhibitor, Vemurafenib, a clinical anticancer drug.
The authors said, “Our study offers the first direct evidence that the BRAF somatic mutation arising from neural stem cells plays a key role in epileptogenesis in the brain tumor. This study also showed a new therapeutic target for tumor-associated epileptic disorders.”
In collaboration with the KAIST startup company, SoVarGen, the research team is currently developing innovative therapeutics for epileptic seizures derived from pediatric brain tumors. This study was supported by the Suh Kyungbae Foundation (SUHF) and the Citizens United for Research in Epilepsy.
(Figure: Preoperative and postoperative brain MRI (left panel), tumor H&E (right upper panel) and GFAP immunohistochemical (right lower panel) staining images from a patient with ganglioglioma (GG231) carrying the BRAFV600E mutation. The white arrow and the black arrowhead indicate the brain tumor and a dysplastic neuron, respectively.)
“KAIST Space Institute will present a new paradigm for space research and education, foster creative talents, and become a space research center to lead the advancement of national space initiatives” (KAIST President Kwang-Hyung Lee) < Vision Declaration Ceremony Photo during Space Research Institute Opening Ceremony > KAIST (President Kwang-Hyung Lee opened the ‘Space Institute’, which brings together all of KAIST’s space technology capabilities to re
2024-09-30Stretchable displays, praised for their spatial efficiency, design flexibility, and human-like flexibility, are seen as the next generation of display technology. A team of Korean researchers has developed a stretchable display that can expand by 25% while maintaining clear image quality without distortion. It can also stretch and contract up to 5,000 times at 15% expansion without any performance degradation, making it the first deformation-free stretchable display with a negative Poisson's rat
2024-09-20< Photos from KAIST-POSTECH Science War (photographed by Student Junhyeok Park of KAIST Freshman Course) > The future leaders of science at KAIST and POSTECH (President Seong Keun Kim) held their annual science and sporting event at POSTECH for two days from September 20th to 21st. The 'KAIST-POSTECH Science War (hereafter KA-PO War)' is a festival consisting of science and sports games and various side events to promote exchange and cooperation between the two universities. It is als
2024-09-19< (From left) Professor Jimin Park of the Department of Chemical and Biomolecular Engineering and Dr. Inho Kim, a graduate of the Department of Materials Science and Engineering > KAIST (represented by President Kwang-Hyung Lee) announced on the 13th of September that Professor Jimin Park from KAIST’s Department of Chemical and Biomolecular Engineering and Dr. Inho Kim, a graduate from the Department of Materials Science and Engineering (currently a postdoctoral researcher at Ca
2024-09-13< Photo. Scholars gatheres for NRF Information Session at Chung Keun Mo Hall > KAIST’s International Office, headed by Vice President Soyoung Kim, successfully organized the ‘NRF Information Session for International Scholars’ on September 11, 2024, in collaboration with the National Research Foundation of Korea (NRF). The event was held at KAIST’s main campus to enourage the international scholar’s active participation in research projects and suppor
2024-09-13